McKesson Corporation

NYSE:MCK

$525.88 USD

$4.47 (0.86%)

Volume
721.5K
Average Volume
816.37K
Market Capitalization
$69.1B
P/E Ratio
23.38
Dividend Yield
0.46%
Price Target
$450.00
Year High
$531.19
Year Low
$331.75
Payout Ratio
$0.10
Current Ratio
$0.92

Industry, Sector & symbol

Stock Exchange New York Stock Exchange
CEO Mr. Brian S. Tyler Ph.D.
Industry Medical Distribution
Sector Healthcare
Current Symbol MCK
CUSIP 58155Q103
CIK 0000927653
Web https://www.mckesson.com
Phone 972 446 4800
Currency USD
Employees 45000
Country US

Liquidity

Debt-to-Equity Ratio -3.71
Payout Ratio 0.10
Current Ratio 0.92
Quick Ratio 0.48
Cash Ratio 0.04

Sales & Book Value

Annual Sales $276.71B
Price / Sales 0.23
Cash Flow 21.70
Price / Cash Flow 23.90
Price / Book -34.15

Price Target and Rating

Average Stock Price Forecast $450.00
High Stock Price Forecast $567.00
Low Stock Price Forecast $257.00
Forecast Upside/Downside 16.86%
Consensus Rating Neutral
Rating Score(0-5) 3
Research Coverage 7 Analysts

Profitability

EPS (Most Recent Fiscal Year) $25.03
Trailing P/E Ratio 23.38
PEG Ratio 3.52
P/E Growth 3.52
Net Income $3.56B
Net Margin 0.99%
Pretax Margin 1.18%
Return on Equity -163.38%
Return on Assets 4.51%

Financials Score

AltmanZ Score 5.55
Piotroski Score 6.00
Working Capital -4.02B
Total Assets 66.51B
Ebit 3.7B
Market Cap 69.1B
Total Liabilities 68.19B

Poll Results

About McKesson Corporation (NYSE:MCK) Stock

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and re ... tail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys; connects pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions; and provides third-party logistics and wholesale distribution support solutions. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Are Investors Undervaluing McKesson (MCK) Right Now?

2024-02-28 10:46:19

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

McKesson (MCK) Hits 52-Week High: What's Driving the Stock?

2024-02-27 12:11:05

Investors are optimistic about McKesson's (MCK) strength in its Biologics business.

Here's Why McKesson (MCK) is a Strong Value Stock

2024-02-20 10:41:12

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

McKesson: GLP-1 Contributed More Than 1/3 Of Growth

2024-02-19 03:22:56

McKesson reported 15% topline growth and 12.2% adjusted EPS growth in their recent earnings report. The company's GLP-1 medications have shown impressive growth, contributing 60% to year-over-year growth. McKesson's strong distribution network and the increasing demand for GLP-1 medications position them for continued growth opportunities.

3 Attractive Medical Stocks to Buy After Earnings

2024-02-08 16:56:14

Following their favorable quarterly results this week here are three intriguing healthcare stocks that investors will want to consider.

Frequently Asked Questions

What is the current McKesson Corporation (MCK) stock price?

McKesson Corporation(NYSE:MCK) stock price is $525.88 in the last trading session. During the trading session, MCK stock reached the peak price of $531.19 while $331.75 was the lowest point it dropped to. The percentage change in MCK stock occurred in the recent session was 0.86% while the dollar amount for the price change in MCK stock was $4.47.

MCK's industry and sector of operation?

The NYSE listed MCK is part of Medical Distribution industry that operates in the broader Healthcare sector.

Who are the executives of MCK?

Ms. Michele Lau | Executive Vice President & Chief Legal Officer
Mr. Napoleon B. Rutledge Jr. | Senior Vice President, Controller & Chief Accounting Officer
Mr. Britt J. Vitalone | Executive Vice President & Chief Financial Officer
Ms. Lori A. Schechter J.D. | Board & Enterprise Risk Advisor
Rachel Rodriguez | Vice President of Investor Relations

How many employees does MCK have?

Number of MCK employees currently stands at 45000. MCK operates from 6555 State Highway 161, Irving, TX 75039, US.

Link for MCK official website?

Official Website of MCK is: https://www.mckesson.com

How do I contact MCK?

MCK could be contacted at phone #972 446 4800 and can also be accessed through its website. MCK operates from 6555 State Highway 161, Irving, TX 75039, US.

How many shares of MCK are traded daily?

The average number of MCK shares traded daily for last 3 months was 816.37K.

What is the market cap of MCK currently?

The market value of MCK currently stands at $69.1B with its latest stock price at $525.88